Cleared Traditional

K072823 - MERILAS 532A

K072823 is an FDA 510(k) clearance for MERILAS 532A, manufactured by Meridian AG. The device is a Class 2 Ophthalmic device with product code HQF cleared through the Traditional 510(k) pathway after a 73-day FDA review.

K072823 · Meridian AG · Ophthalmic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2007
Decision
73d
Days
Class 2
Risk

K072823 is an FDA 510(k) clearance for the MERILAS 532A. Classified as Laser, Ophthalmic (product code HQF), Class II - Special Controls.

Submitted by Meridian AG (Littleton, US). The FDA issued a Cleared decision on December 14, 2007 after a review of 73 days - a notably fast clearance cycle.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.4390 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Meridian AG devices

FDA 510(k) Submission Details - K072823

510(k) Number K072823 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 02, 2007
Decision Date December 14, 2007
Days to Decision 73 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
37d faster than avg
Panel avg: 110d · This submission: 73d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

HQF Device Classification - Class 2, Special Controls

Product Code HQF Laser, Ophthalmic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 886.4390
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.

Regulatory Peers - HQF Laser, Ophthalmic

All 153
Devices cleared under the same product code (HQF) and FDA review panel - the closest regulatory comparables to K072823.
SOLX 790 TITANIUM SAPPHIRE LASER
K081774 · Solx, Inc. · Sep 2008
INTEGRE PRO, MODEL L2RY
K081565 · Ellex Medical Pty, Ltd. · Jul 2008
INTEGRE, MODEL LP581
K080423 · Ellex Medical Pty, Ltd. · Mar 2008
NEXT GENERATION LASER
K062624 · Alcon Laboratories · Nov 2007
LIGHTLAS 561 OPTHALMIC PHOTOCOAGULATOR
K063297 · Lightmed Corp. · Sep 2007
SUPRA OPHTHALMIC LASER PHOTOCOAGULATOR
K070776 · Quantel Medical · Apr 2007